Article(id=1236360795244786148, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1236360790672986545, articleNumber=null, orderNo=null, doi=null, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=null, receivedDateStr=null, revisedDate=null, revisedDateStr=null, acceptedDate=1698595200000, acceptedDateStr=2023-10-30, onlineDate=1772700984059, onlineDateStr=2026-03-05, pubDate=1703865600000, pubDateStr=2023-12-30, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1772700984059, onlineIssueDateStr=2026-03-05, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1772700984059, creator=13701087609, updateTime=1772700984059, updator=13701087609, issue=Issue{id=1236360790672986545, tenantId=1146029695717560320, journalId=1235980733773295621, year='2023', volume='32', issue='24', pageStart='2441', pageEnd='2543', issueExtLink='null', onlineDate='null', pubDate='null', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1772700982968, creator=13701087609, updateTime=1772701059772, updator=13701087609, preIssue=null, nextIssue=null, ext={EN=IssueExt(id=1236361112883622634, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1236360790672986545, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1236361112883622635, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1236360790672986545, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null}, startPage=2495, endPage=2500, ext={EN=ArticleExt(id=1236360795479667173, articleId=1236360795244786148, tenantId=1146029695717560320, journalId=1235980733773295621, language=EN, title=Research progress in SARS-CoV-2 neutralizing antibody products and pharmaceutical assessment, columnId=null, journalTitle=Chinese Journal of New Drugs, columnName=null, runingTitle=null, highlight=null, articleAbstract=

Repeated SARS-CoV-2 infections still threaten public health around the world. Researchers are still committed to carrying out research on vaccines, small molecular antiviral drugs, and neutralizing antibodies to find more effective means of prevention and treatment for the infection of various mutants of novel coronavirus. Among them, neutralizing antibodies have the advantages of clear action mechanism, good safety, and convenience for large-scale production, so they are one of the therapeutic class of drugs with best potential to treat COVID-19. The research and development projects for SARS-CoV-2 neutralizing antibodies have been developing rapidly both at home and abroad. This paper briefly introduces the research status of SARS-CoV-2 neutralizing antibodies, focusing on providing special considerations for pharmaceutical evaluation of these class of drugs in combination with the practice of drug evaluation to promote the industrialization of the same class of domestic products as soon as possible.

, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, authorCompany=null, fund=null, authors=null, authorsList=Dong-chen JIA, Zhou-yi WU, Peng-li YU), CN=ArticleExt(id=1236360795706159591, articleId=1236360795244786148, tenantId=1146029695717560320, journalId=1235980733773295621, language=CN, title=新型冠状病毒中和抗体类药物的研究进展与药学评价, columnId=1236331159400018080, journalTitle=中国新药杂志, columnName=新药注册与审评技术, runingTitle=null, highlight=null, articleAbstract=

新型冠状病毒的反复感染仍威胁着全球公众健康。研究人员依然致力于从疫苗、小分子抗病毒药物和中和抗体等多方面开展研究,为新型冠状病毒各类变异株的感染寻找更为有效的预防、治疗手段。其中,中和抗体具有作用机制明确、安全性高、便于大规模生产等优势,是极具潜力的新型冠状病毒肺炎(COVID-19)治疗药物之一,国内外针对新型冠状病毒中和抗体的研发项目发展迅速,本文简要介绍新型冠状病毒中和抗体研究现状,重点结合审评实践,提出对于此类品种药学评价的特殊考虑,以期促进国内同类产品尽快实现产业化。

, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=《中国新药杂志》有限公司, extLink=null, articleAbsUrl=null, sourceXml=y+1kadpsaDbkU04cha5Naw==, magXml=8n6FdoWrJd/jZnrqqEuU2w==, pdfUrl=null, pdf=TdAHX6Pi0cnPfS5A4OVPxA==, pdfFileSize=1320619, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=p4l1Gm+BbcwyWo1BxH5ZOg==, mapNumber=null, authorCompany=null, fund=null, authors=

贾东晨,女,主管药师,主要从事生物制品药学审评工作。E-mail:

, authorsList=贾东晨, 吴舟一, 于鹏丽)}, authors=[Author(id=1236360796100424176, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360795244786148, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=nmgjdc@126.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1236360796171727347, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360795244786148, authorId=1236360796100424176, language=EN, stringName=Dong-chen JIA, firstName=Dong-chen, middleName=null, lastName=JIA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1236360796259807732, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360795244786148, authorId=1236360796100424176, language=CN, stringName=贾东晨, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100076, bio={"content":"

贾东晨,女,主管药师,主要从事生物制品药学审评工作。E-mail:

"}, bioImg=null, bioContent=

贾东晨,女,主管药师,主要从事生物制品药学审评工作。E-mail:

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1236360795991372268, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360795244786148, xref=null, ext=[AuthorCompanyExt(id=1236360795995566573, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360795244786148, companyId=1236360795991372268, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, China), AuthorCompanyExt(id=1236360796012343790, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360795244786148, companyId=1236360795991372268, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100076)])]), Author(id=1236360796331110906, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360795244786148, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1236360796406608380, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360795244786148, authorId=1236360796331110906, language=EN, stringName=Zhou-yi WU, firstName=Zhou-yi, middleName=null, lastName=WU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1236360796536631810, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360795244786148, authorId=1236360796331110906, language=CN, stringName=吴舟一, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100076, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1236360795991372268, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360795244786148, xref=null, ext=[AuthorCompanyExt(id=1236360795995566573, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360795244786148, companyId=1236360795991372268, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, China), AuthorCompanyExt(id=1236360796012343790, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360795244786148, companyId=1236360795991372268, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100076)])]), Author(id=1236360796603740679, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360795244786148, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1236360796687626763, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360795244786148, authorId=1236360796603740679, language=EN, stringName=Peng-li YU, firstName=Peng-li, middleName=null, lastName=YU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1236360796775707154, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360795244786148, authorId=1236360796603740679, language=CN, stringName=于鹏丽, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100076, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1236360795991372268, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360795244786148, xref=null, ext=[AuthorCompanyExt(id=1236360795995566573, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360795244786148, companyId=1236360795991372268, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, China), AuthorCompanyExt(id=1236360796012343790, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360795244786148, companyId=1236360795991372268, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100076)])])], keywords=[Keyword(id=1236360796876370456, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360795244786148, language=EN, orderNo=1, keyword=SARS-CoV-2 neutralizing antibodies), Keyword(id=1236360796943479325, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360795244786148, language=EN, orderNo=2, keyword=pharmaceutical assessment), Keyword(id=1236360797018976803, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360795244786148, language=EN, orderNo=3, keyword=special dosage form), Keyword(id=1236360797115445798, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360795244786148, language=CN, orderNo=1, keyword=新型冠状病毒中和抗体), Keyword(id=1236360797174166059, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360795244786148, language=CN, orderNo=2, keyword=药学评价), Keyword(id=1236360797253857841, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360795244786148, language=CN, orderNo=3, keyword=特殊剂型)], refs=null, funds=null, companyList=[AuthorCompany(id=1236360795991372268, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360795244786148, xref=null, ext=[AuthorCompanyExt(id=1236360795995566573, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360795244786148, companyId=1236360795991372268, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, China), AuthorCompanyExt(id=1236360796012343790, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360795244786148, companyId=1236360795991372268, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100076)])], figs=null, attaches=null, journal=Journal(id=1235980159023624194, delFlag=0, nameCn=中国新药杂志, nameEn=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, issn=1003-3734, eissn=null, cn=11-2850/R, coden=ZXZHA6, periodic=3, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of New Drugs, journalRemark=null, publicationField=null, createdTime=1772610233314, updatedTime=1772610649152, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=C, firstLetterEn=C, subjectCode=Life Sciences, subjectName=null, subjectCodeEn=Life Sciences, subjectNameEn=null, picCn=ohPEEN//Vz1tDT3ZBNTp4Q==, picEn=f9WK9bvTM4guTmS/iGhOMg==, jcr=null, cjcr=null, exts=[JournalExt(id=1235981903275290962, language=CN, name=中国新药杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1772610649174, updatedTime=1772610649174, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1235981903338205523, language=EN, name=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1772610649189, updatedTime=1772610649189, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1235980733773295621, websiteList=[Website(id=1235982099191222761, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/CN, language=CN, createTime=1772610695884, createBy=18614031015, updateTime=1772610860397, updateBy=18614031015, name=中国新药杂志-中文, tplId=1146099689490845704, title=中国新药杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983918629966444, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=articleTextType, value=kx, createTime=1772611129672, updateTime=1772611129672, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918604800617, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=banner, value=null, createTime=1772611129666, updateTime=1772611129666, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918655132271, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=grayFlag, value=0, createTime=1772611129678, updateTime=1772611129678, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918596412008, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611129664, updateTime=1772611129664, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918667715185, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=minRunFlag, value=0, createTime=1772611129681, updateTime=1772611129681, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918617383531, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic, createTime=1772611129669, updateTime=1772611129669, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918659326576, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=silenceFlag, value=0, createTime=1772611129679, updateTime=1772611129679, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918613189226, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1772611129668, updateTime=1772611129668, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918634160749, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeColor, value=null, createTime=1772611129673, updateTime=1772611129673, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918646743662, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeStyle, value=null, createTime=1772611129676, updateTime=1772611129676, creator=18614031015, updator=18614031015)]), Website(id=1235982099270914542, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/EN, language=EN, createTime=1772610695903, createBy=18614031015, updateTime=1772610875891, updateBy=18614031015, name=中国新药杂志-英文, tplId=1146101810881728533, title=Chinese Journal of New Drugs, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983955829248630, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=articleTextType, value=kx, createTime=1772611138541, updateTime=1772611138541, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955804082803, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=banner, value=null, createTime=1772611138535, updateTime=1772611138535, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955854414457, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=grayFlag, value=0, createTime=1772611138547, updateTime=1772611138547, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955795694194, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611138533, updateTime=1772611138533, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955866997371, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=minRunFlag, value=0, createTime=1772611138550, updateTime=1772611138550, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955820860021, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic, createTime=1772611138539, updateTime=1772611138539, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955862803066, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=silenceFlag, value=0, createTime=1772611138549, updateTime=1772611138549, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955812471412, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1772611138537, updateTime=1772611138537, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955837637239, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeColor, value=null, createTime=1772611138543, updateTime=1772611138543, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955846025848, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeStyle, value=null, createTime=1772611138545, updateTime=1772611138545, creator=18614031015, updator=18614031015)])], journalTitle=中国新药杂志, weixinUrl=null, journalUrl=http://www.newdrug.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of New Drugs, journalPhotoCn=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPhotoEn=f9WK9bvTM4guTmS/iGhOMg==, journalFirstLetter=C, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/Y2023/V32/I24/2495, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/Y2023/V32/I24/2495, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/PDF/Y2023/V32/I24/2495, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/PDF/Y2023/V32/I24/2495, aliStartDate=null, aliEndDate=null, collectionFlag=false, citedCount=null, citedUrl=null, reference=null)
收藏切换
新型冠状病毒中和抗体类药物的研究进展与药学评价
收藏切换
PDF下载
贾东晨 , 吴舟一 , 于鹏丽
中国新药杂志 | 新药注册与审评技术 2023,32(24): 2495-2500
收起
收藏切换
中国新药杂志 | 新药注册与审评技术 2023, 32(24): 2495-2500
新型冠状病毒中和抗体类药物的研究进展与药学评价
全屏
贾东晨 , 吴舟一, 于鹏丽
作者信息
  • 国家药品监督管理局药品审评中心,北京 100076
  • 贾东晨,女,主管药师,主要从事生物制品药学审评工作。E-mail:

Research progress in SARS-CoV-2 neutralizing antibody products and pharmaceutical assessment
Dong-chen JIA , Zhou-yi WU, Peng-li YU
Affiliations
  • Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, China
出版时间: 2023-12-30
文章导航
收藏切换

新型冠状病毒的反复感染仍威胁着全球公众健康。研究人员依然致力于从疫苗、小分子抗病毒药物和中和抗体等多方面开展研究,为新型冠状病毒各类变异株的感染寻找更为有效的预防、治疗手段。其中,中和抗体具有作用机制明确、安全性高、便于大规模生产等优势,是极具潜力的新型冠状病毒肺炎(COVID-19)治疗药物之一,国内外针对新型冠状病毒中和抗体的研发项目发展迅速,本文简要介绍新型冠状病毒中和抗体研究现状,重点结合审评实践,提出对于此类品种药学评价的特殊考虑,以期促进国内同类产品尽快实现产业化。

新型冠状病毒中和抗体  /  药学评价  /  特殊剂型

Repeated SARS-CoV-2 infections still threaten public health around the world. Researchers are still committed to carrying out research on vaccines, small molecular antiviral drugs, and neutralizing antibodies to find more effective means of prevention and treatment for the infection of various mutants of novel coronavirus. Among them, neutralizing antibodies have the advantages of clear action mechanism, good safety, and convenience for large-scale production, so they are one of the therapeutic class of drugs with best potential to treat COVID-19. The research and development projects for SARS-CoV-2 neutralizing antibodies have been developing rapidly both at home and abroad. This paper briefly introduces the research status of SARS-CoV-2 neutralizing antibodies, focusing on providing special considerations for pharmaceutical evaluation of these class of drugs in combination with the practice of drug evaluation to promote the industrialization of the same class of domestic products as soon as possible.

SARS-CoV-2 neutralizing antibodies  /  pharmaceutical assessment  /  special dosage form
贾东晨, 吴舟一, 于鹏丽. 新型冠状病毒中和抗体类药物的研究进展与药学评价. 中国新药杂志, 2023 , 32 (24) : 2495 -2500 .
Dong-chen JIA, Zhou-yi WU, Peng-li YU. Research progress in SARS-CoV-2 neutralizing antibody products and pharmaceutical assessment[J]. Chinese Journal of New Drugs, 2023 , 32 (24) : 2495 -2500 .
2023年第32卷第24期
PDF下载
35
9
引用本文
BibTeX
文章信息
  • 首发时间:2026-03-05
  • 出版时间:2023-12-30
补充材料
相关文章
文章信息
作者
出版历史
  • 录用日期:2023-10-30
基金
作者信息
    国家药品监督管理局药品审评中心,北京 100076
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgxyzz/CN/1236360795244786148
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏